stockrowBioCryst Pharmaceuticals, Inc. (BCRX) vs Trulieve Cannabis Corp. (TRLV)
- BioCryst Pharmaceuticals, Inc. BCRX 7.55 −8.37%
- Trulieve Cannabis Corp. TRLV 11.07 −4.57%
BioCryst Pharmaceuticals, Inc. and Trulieve Cannabis Corp. are both Drug Manufacturers Specialty & Generic companies. BioCryst Pharmaceuticals, Inc. and Trulieve Cannabis Corp. are of similar size ($2.1B and $2.0B). BioCryst Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 60.3% against −9.09%. BioCryst Pharmaceuticals, Inc. has the higher net margin (−37.4% vs −41.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, BioCryst Pharmaceuticals, Inc. leads on 10 and Trulieve Cannabis Corp. on 6.
Valuation
Profitability
| Metric | BCRX | TRLV | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.89% | 60.64% | 53.51% |
| Operating margin | (30.10%) | 0.00% | 0.00% |
| Net margin | (37.41%) | (41.22%) | (2.45%) |
| Free cash flow margin | 38.11% | 22.43% | 0.00% |
| Return on equity | 91.60% | (45.52%) | (0.80%) |
| Return on assets | (69.33%) | (17.61%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack